Adicet Bio, Inc. (ACET) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of Adicet Bio, Inc. and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adicet Bio, Inc. logo
ACET
Adicet Bio, Inc.
$61M
$6.54HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$58M
$11.71HealthcareDelayed quote: Oct 6, 2026, 11:29 AM EDT

Total return — ACET vs INKT

growth of $100 · dividends reinvested · last 5y
ACET -94.9% (-44.9%/yr)INKT -89.8% (-36.7%/yr)INKT compounded faster over this window
0100200Start $10020222023202420252026$5$10
ACET INKT

ACET vs INKT: by the numbers

  • •ACET is the larger company ($61M vs $58M market cap).

Metrics side by side

Valuation

MetricACETINKT
P/B ratio0.51N/A

Profitability

MetricACETINKT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-82.38%N/A
ROIC-79.68%-604.20%

Growth (annualized)

MetricACETINKT
Total return CAGR (5Y)-44.24%N/A

Go deeper

Full ACET analysisFull INKT analysisInteractive comparison tool

Dig into the metrics

Adicet Bio ROEMiNK Therapeutics ROEAdicet Bio operating marginMiNK Therapeutics operating marginAdicet Bio revenue growthMiNK Therapeutics revenue growthAdicet Bio free cash flowMiNK Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.